Stock Market Today, Jan. 16: ImmunityBio Soars After Anktiva Revenue Jumps 700 Percent Year Over Year [Yahoo! Finance]
Krystal Biotech, Inc. (KRYS)
Last krystal biotech, inc. earnings: 11/4 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.krystalbio.com/investors
Company Research
Source: Yahoo! Finance
The stock climbed after Premarket updates highlighted explosive Anktiva revenue growth, positive oncology trial data, and new regulatory approvals, and investors are watching upcoming BLA plans and broader Anktiva commercialization traction next. Trading volume reached 176 million shares, about 1,254% above its three-month average of 13 million shares. ImmunityBio IPO'd in 2015 and has fallen 85% since going public. The S&P 500 (SNPINDEX:^GSPC) slipped 0.06% to 6,940, while the Nasdaq Composite (NASDAQINDEX:^IXIC) eased 0.06% to finish at 23,515. (NASDAQ:IOVA) (NASDAQ:IOVA) and Krystal Biotech (NASDAQ:KRYS) , were up 6.31% and 1.07%, respectively, today. Iovance Biotherapeutics (NASDAQ:IOVA) closed at $2.36, up 6.31%, and Krystal Biotech (NASDAQ:KRYS) ended at $285.04, gaining 1.07%, as investors reassessed oncology drug developers. Today's stock movement could be attributed to the news before the market opened that the company's preliminary 2025 net product revenue for its drug
Show less
Read more
Impact Snapshot
Event Time:
KRYS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KRYS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KRYS alerts
High impacting Krystal Biotech, Inc. news events
Weekly update
A roundup of the hottest topics
KRYS
News
- What Does Wall Street Think About Krystal Biotech (KRYS)? [Yahoo! Finance]Yahoo! Finance
- Krystal Biotech: Beyond VYJUVEK Commercialization [Seeking Alpha]Seeking Alpha
- Krystal Biotech (NASDAQ:KRYS) had its price target raised by analysts at Citigroup Inc. from $320.00 to $336.00. They now have a "buy" rating on the stock.MarketBeat
- Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
KRYS
Earnings
- 11/3/25 - Beat
KRYS
Sec Filings
- 1/12/26 - Form 8-K
- 1/8/26 - Form 8-K
- 12/23/25 - Form 8-K
- KRYS's page on the SEC website